Carelabs Co.,Ltd (KOSDAQ:263700)
South Korea · Delayed Price · Currency is KRW 2,760.00
+140.00 (5.34%)
At close: Apr 17, 2026
Carelabs Co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 81,694 | 83,187 | 81,827 | 87,607 | 93,934 |
| 81,694 | 83,187 | 81,827 | 87,607 | 93,934 | |
Revenue Growth (YoY) | -1.80% | 1.66% | -6.60% | -6.73% | 22.52% |
Cost of Revenue | 1,678 | 1,187 | 2,253 | 3,157 | 4,857 |
Gross Profit | 80,016 | 82,000 | 79,574 | 84,451 | 89,077 |
Selling, General & Admin | 77,644 | 79,567 | 81,761 | 83,205 | 78,782 |
Research & Development | 2,048 | 2,559 | 3,811 | 2,767 | 3,502 |
Amortization of Goodwill & Intangibles | 490.96 | 520.19 | 698.6 | 1,294 | 1,369 |
Other Operating Expenses | 410.42 | 474.29 | 583.38 | 492.57 | 453.78 |
Operating Expenses | 82,908 | 86,485 | 91,273 | 91,131 | 86,771 |
Operating Income | -2,892 | -4,485 | -11,698 | -6,681 | 2,306 |
Interest Expense | -1,390 | -3,118 | -2,996 | -2,504 | -1,502 |
Interest & Investment Income | 1,030 | 865.38 | 694.04 | 761.71 | 456.59 |
Earnings From Equity Investments | 310.38 | -566.9 | 175.16 | 4.53 | 625.93 |
Currency Exchange Gain (Loss) | -4.75 | -5.7 | -10.14 | 101.52 | -5.24 |
Other Non Operating Income (Expenses) | -244.06 | 7,260 | -1,930 | -5,255 | -176.1 |
EBT Excluding Unusual Items | -3,190 | -50.19 | -15,765 | -13,573 | 1,705 |
Gain (Loss) on Sale of Investments | 984.09 | -8,320 | -1,678 | -480.37 | 4,418 |
Gain (Loss) on Sale of Assets | 25,635 | -4,496 | -306.12 | -1,735 | 16.53 |
Asset Writedown | - | -6,277 | -4,434 | -10,979 | -2,204 |
Other Unusual Items | - | 4.66 | 535.39 | -22.13 | - |
Pretax Income | 23,429 | -19,139 | -21,648 | -26,789 | 3,936 |
Income Tax Expense | 3,918 | 531.11 | 2,219 | -400.36 | 2,694 |
Earnings From Continuing Operations | 19,512 | -19,670 | -23,867 | -26,388 | 1,242 |
Minority Interest in Earnings | -332.42 | -610.34 | -603.28 | 264.48 | 11.02 |
Net Income | 19,179 | -20,280 | -24,470 | -26,124 | 1,253 |
Net Income to Common | 19,179 | -20,280 | -24,470 | -26,124 | 1,253 |
Net Income Growth | - | - | - | - | -71.06% |
Shares Outstanding (Basic) | 19 | 19 | 19 | 18 | 17 |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 18 | 17 |
Shares Change (YoY) | -0.07% | 2.25% | 5.73% | 4.14% | -0.11% |
EPS (Basic) | 989.00 | -1045.00 | -1289.28 | -1455.20 | 72.70 |
EPS (Diluted) | 989.00 | -1045.00 | -1289.28 | -1455.20 | 72.70 |
EPS Growth | - | - | - | - | -74.44% |
Free Cash Flow | -15,179 | -4,202 | -12,536 | -9,816 | -40,071 |
Free Cash Flow Per Share | -782.71 | -216.51 | -660.50 | -546.80 | -2324.59 |
Gross Margin | 97.95% | 98.57% | 97.25% | 96.40% | 94.83% |
Operating Margin | -3.54% | -5.39% | -14.30% | -7.63% | 2.46% |
Profit Margin | 23.48% | -24.38% | -29.90% | -29.82% | 1.33% |
Free Cash Flow Margin | -18.58% | -5.05% | -15.32% | -11.21% | -42.66% |
EBITDA | 27.76 | -829.86 | -7,273 | -2,650 | 5,128 |
EBITDA Margin | 0.03% | -1.00% | -8.89% | -3.02% | 5.46% |
D&A For EBITDA | 2,919 | 3,655 | 4,426 | 4,030 | 2,821 |
EBIT | -2,892 | -4,485 | -11,698 | -6,681 | 2,306 |
EBIT Margin | -3.54% | -5.39% | -14.30% | -7.63% | 2.46% |
Effective Tax Rate | 16.72% | - | - | - | 68.45% |
Advertising Expenses | 14,571 | 13,708 | 11,898 | 11,308 | 5,399 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.